Cite
APA Citation
Berek, J. S., Matulonis, U. A., Peen, U., Ghatage, P., Mahner, S., Redondo, A., Lesoin, A., Colombo, N., Vergote, I., Rosengarten, O., Ledermann, J., Pineda, M., Ellard, S., Sehouli, J., Gonzalez-Martin, A., Berton-Rigaud, D., Madry, R., Reinthaller, A., Hazard, S., Guo, W., & Mirza, M. R. (2019). safety and dose modification for patients receiving niraparib. Annals of oncology, 30, 859. http://access.bl.uk/ark:/81055/vdc_100092197815.0x000038